Effect of Clarithromycin in Inflammatory Markers of Patients with Ventilator-Associated Pneumonia and Sepsis Caused by Gram-Negative Bacteria: Results from a Randomized Clinical Study

One recent, double-blind, randomized clinical trial with 200 patients showed that clarithromycin administered intravenously for 3 days in patients with ventilator-associated pneumonia (VAP) accelerated the resolution of pneumonia and decreased the risk of death from septic shock and multiple organ d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Spyridaki, Aikaterini, Raftogiannis, Maria, Antonopoulou, Anastasia, Tsaganos, Thomas, Routsi, Christina, Baziaka, Fotini, Karagianni, Vassiliki, Mouktaroudi, Maria, Koutoukas, Pantelis, Pelekanou, Aimilia, Kotanidou, Anastasia, Orfanos, Stylianos E., van der Meer, Jos W. M., Netea, Mihai G., Giamarellos-Bourboulis, Evangelos J.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2012
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3393410/
https://ncbi.nlm.nih.gov/pubmed/22564837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05798-11
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars